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Background: Soluble fms-like tyrosine kinase-1 (sFLT-1) antagonizes vascular endothelial growth factor and placental growth factor (PlGF) and 
regulates apoptosis in vascular smooth muscle cells. sFLT-1 levels predict clinical events in systolic heart failure (HF); however, the association of 
sFLT-1 with other outcomes in HF has not been reported.
Methods: We examined the association of baseline levels of sFLT-1, PlGF, and sFLT-1 to PlGF ratio with (1) clinical events (death, transplantation, 
ventricular assist device implantation) and (2) admissions and emergency department [ED] visits in 173 stable HF outpatients (age, 57±12 yrs; 63% 
men; 58% white; 38% black; ejection fraction [EF] 29±15%) enrolled in a prospective cohort study.
Results: Over 32±8 months (total: 465 person-years), there were 27 (15.6%) clinical events (22 deaths, 4 transplants, 1 ventricular assist device), 
413 all-cause admissions (167 [40.4%] for HF), and 199 ED visits. Baseline sFLT-1, PlGF, and sFLT-1/PlGF were 339±83 pg/ml, 19.2±5.1 pg/ml, and 
18.9±7.4, respectively. Compared to the lower sFLT-1 tertile, patients in the upper tertile had (1) increased risk for clinical events (HR 4.5; 95% CI 
1.2-17.3; P=0.029) and (2) higher healthcare resource utilization rates (Figure) in models adjusted for age, gender, race, systolic blood pressure, 
creatinine, NYHA class and EF. PlGF and sFLT-1/PlGF were not predictive of outcomes.
Conclusion: Increased sFLT-1 but not PlGF levels are associated with worse outcomes in HF outpatients.
 
